Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 3 years ago

Possible Interaction: Ranolazine and Calcium Supplement

Research Papers that Mention the Interaction

More ecent evidence suggests that ranolazine prevents ischemiaelated calcium and sodium overload by blocking the late odium current.
Heart rhythm  •  2011  |  View Paper
Ranolazine reduces Na overload induced by calcium and improves diastolic relaxation and coronary subendocardial flow, without affecting hemodynamic parameters such as blood pressure, heart rate, or inotropic state of the heart, avoiding undesirable side effects.
Giornale italiano di cardiologia  •  2012  |  View Paper
Ranolazine thereby reduces intracellular sodium and calcium accumulation during ischemia, as shown in various animal research models.
Expert review of cardiovascular therapy  •  2010  |  View Paper
Ranolazine , a selective inhibitor of the late sodium current, can reduce sodium accumulation and Ca 2 + overload.
Journal of cellular physiology  •  2019  |  View Paper
Ranolazine inhibits sodium voltage-dependent channels, suggesting their possible involvement in the reperfusion process by preventing the sodium and calcium overload that occurs during ischemia.
Revista espanola de cardiologia  •  2016  |  View Paper
Ranolazine (10 μM), but not lidocaine (10 μM), reduced RM NCX1.1-mediated Ca2+i overload in ventricular myocytes.
Ranolazine and lidocaine (10 μM) similarly reduced Ca2+i overload and improved left ventricle work recovery in whole-heart models of IR injury or exposure to ouabain (80 μM).
Journal of Pharmacology and Experimental Therapeutics  •  2012  |  View Paper
Ranolazine may provide functional protection of the heart during IR injury by reducing cCa2+ and mCa2+ loading secondary to its effect to block the late Na+ current.
Pharmacological research  •  2011  |  View Paper
Reduction by RAN of INa,L-induced dysregulation of calcium cycling could contribute to the antiarrhythmic actions of this agent in both reentrant and triggered arrhythmias.
Journal of Pharmacology and Experimental Therapeutics  •  2009  |  View Paper
In working hearts, 10 micromol/L ranolazine significantly increased glucose oxidation 1.5-fold to 3-fold under conditions in which the contribution of glucose to overall ATP production was low (low Ca , high FA, with insulin), high (high Ca, low Fa, with pacing), or intermediate.
Circulation  •  1996  |  View Paper
Ranolazine induces in fact a reduction of the intracellular late sodium current that leads to a reduction of the intracellular calcium concentration thus producing a better myocardial diastolic relaxation process which in its turns enhances the myocardial perfusion.
Case reports in cardiology  •  2013  |  View Paper
Show More